Vesigen Receives National Institutes of Health Award in Targeted Genome Editor Delivery Challenge
Vesigen proposal selected as a “Winning Solution" for programmable delivery systems for gene editingProposal builds on recent data demonstrating cell type-specific targeting of Company’s non-viral delivery platformCAMBRIDGE, Mass.--(BUSINESS WIRE)--#ARMMs--Vesigen Therapeutics, Inc., a biotechnology company developi...
Source: pharmiweb.com